Protagonist Therapeutics shares owned by MetLife Investment Advisors
Quarter-by-quarter ownership of Protagonist Therapeutics (PTGX) shares owned by MetLife Investment Advisors
from 13F filings
Historical chart of MetLife Investment Advisors investment in Protagonist Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Protagonist Therapeutics held by MetLife Investment Advisors consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Protagonist Therapeutics by MetLife Investment Advisors
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-12-31 | $656k | 29k | 22.93 |
| 2023-09-30 | $477k | 29k | 16.68 |
| 2023-06-30 | $790k | 29k | 27.62 |
| 2023-03-31 | $550k | 24k | 23.00 |
| 2022-12-31 | $261k | 24k | 10.91 |
| 2022-09-30 | $202k | 24k | 8.43 |
| 2022-06-30 | $189k | 24k | 7.90 |
| 2022-03-31 | $566k | 24k | 23.67 |
| 2021-12-31 | $516k | 15k | 34.20 |
| 2021-09-30 | $267k | 15k | 17.72 |
| 2021-06-30 | $677k | 15k | 44.88 |
| 2021-03-31 | $350k | 14k | 25.90 |
| 2020-12-31 | $273k | 14k | 20.19 |
| 2020-09-30 | $264k | 14k | 19.52 |
| 2020-06-30 | $191k | 11k | 17.69 |
| 2019-09-30 | $109k | 9.1k | 11.96 |
More positions owned by MetLife Investment Advisors
View all positions for MetLife Investment Advisors